Niacinamide
Last reviewed
Niacinamide is vitamin B3 in its amide form, different from niacin, which causes flushing through prostaglandin release. Niacinamide is non-flushing, demonstrates mast cell stabilizing effects in lab models relevant to MCAS, supports NAD+ production, and shows pro-collagen activity in dermal fibroblasts at supplemental doses. ZebraThrive uses 50 mg in the AM stack.
At a Glance
Daily Dose
50 mg AM
Key Benefits
How It Works
Niacinamide is vitamin B3 in its amide form - different from niacin, which causes flushing through prostaglandin release. Niacinamide is non-flushing and historically demonstrates mast cell stabilizing effects in lab models. It supports skin barrier function, NAD+ production, and pro-collagen activity in dermal fibroblasts at concentrations achievable from supplementation. For the triad specifically, we use a conservative 50 mg dose because human data shows higher doses can transiently raise plasma histamine through methylation pathway competition - important to know for an MCAS-aware formulation. At 50 mg, niacinamide hits the benefit profile without the histamine concern.
What the Research Shows
Human data establishes a methylation-competition mechanism by which higher niacinamide doses raise plasma histamine through draw on the methyl donor pool that HNMT also uses. This is the dose-ceiling rationale for our conservative 50 mg/day formulation.
Human PK study
100 mg of niacinamide raised plasma histamine at 5 hours after a single dose; mechanism attributed to methyl donor competition (HNMT and NNMT share the same SAM-dependent methyl pool)
Enzyme kinetics study, NNMT mechanism
Characterized the kinetic mechanism by which NNMT (nicotinamide N-methyltransferase) catalyzes the SAM-dependent methylation of nicotinamide, establishing the biochemical basis for methyl pool depletion at high niacinamide doses
Niacinamide has been extensively reviewed for high-dose safety in the diabetes-prevention literature. Reversible hepatotoxicity has been reported above 3 g/day; minor abnormalities of liver enzymes can occur infrequently. Our 50 mg dose sits two orders of magnitude below the safety threshold.
Literature review of high-dose nicotinamide trials
Therapeutic index is wide; reversible hepatotoxicity reported at doses above 3 g/day in animals and humans; minor liver enzyme abnormalities infrequent at typical study doses; no evidence of teratogenicity or oncogenicity
Comprehensive safety review
Both niacinamide and niacin are non-toxic at levels considerably higher than typical supplemental or cosmetic use; oral bioavailability ~100%, half-life 7-9 hours at higher doses
Niacinamide functions as a complementary B3 form alongside Nicotinamide Riboside for NAD+ pathway support. Recent mechanistic work documents the NAD-boosting class as a mast cell stabilizing pathway through SIRT6 signaling.
Mouse + human cord blood-derived mast cell + cell models
NAD-boosting molecules (NMN and NR) suppress mast cell degranulation through SIRT6 pathway; the same NAD+ axis niacinamide contributes to at a smaller magnitude
Addressing the Triad
Tailored benefits for complex conditions
Niacinamide has mixed evidence in MCAS, and we navigate it carefully. The favorable side: older lab studies (Bekier 1974, 1975) showed niacinamide inhibits mast cell degranulation similarly to cromolyn. The constraint: human data at higher doses raises a methylation/histamine concern, which is why we cap at the conservative dose described in Why This Form. We also include methylfolate and methylated B12 to keep the methyl donor pool topped up. A conservative middle path that respects what the human data actually shows.
For hEDS, niacinamide contributes pro-collagen activity in dermal fibroblasts - part of the broader connective tissue support stack, though not a hero ingredient at our 50 mg dose. The bigger contribution is NAD+ pathway support alongside NR, which feeds the sirtuin-MMP axis (SIRT1/SIRT6 activation reduces MMP-1 and MMP-9 expression in dermal fibroblasts and tenocytes). At our conservative dose, niacinamide is a foundation B-vitamin for hEDS rather than a targeted intervention. The targeted ECM-protective work happens through the polyphenols and direct MMP-modulating ingredients elsewhere in the formulation.
Niacinamide's POTS relevance is mitochondrial: NAD+ pathway support for the chronic fatigue that frequently shadows POTS (many POTS patients also meet ME/CFS criteria). Niacinamide alongside NR provides broader B3 coverage for mitochondrial energy production. The 50 mg dose is deliberately conservative enough not to push methylation balance, which matters because methylation competition can affect catecholamine metabolism - and catecholamine handling is already disordered in POTS. The conservative dose is itself part of the POTS-friendliness, alongside the methylation-supporting B-vitamins that anchor that pathway.
Why We Chose This Form
We use niacinamide (the amide form), not niacin, and at a deliberately conservative 50 mg per day. Niacin causes flushing through prostaglandin release from Langerhans cells - that 'niacin flush' is uncomfortable and can be a problem for sensitive populations. Niacinamide is the non-flushing form. We chose 50 mg specifically because a 2013 human study showed 100 mg raised plasma histamine at 5 hours through methylation depletion - a real consideration for MCAS patients. Half that dose delivers the niacinamide benefit profile without crossing the methylation/histamine threshold.
Safety & Interactions
Potential Side Effects
Excellent safety at the 50 mg dose. Niacinamide is non-flushing (unlike niacin). Very high doses (>3 g/day) have hepatotoxicity concerns; our dose is 50x below that level. No reported acute side effects in healthy populations at supplement doses.
Drug Interactions
At 50 mg, no clinically meaningful interactions with the standard POTS, MCAS, or hEDS medication stack. Theoretical methylation competition with high doses (>500 mg) of other methylation-dependent compounds; the formulation includes methylfolate and methylated B12 to support methyl group availability. Mention to your prescriber if you take additional high-dose B3 separately.
Excipients to Avoid
- Fermentation-derived sources
- Artificial colors
- Magnesium stearate
Safe Excipients
- HPMC capsules
- Rice flour
- Cellulose
- [1]Excess nicotinamide increases plasma serotonin and histamine levelsPMID: 23426511
Tian YJ et al. (2013)
- [2]Kinetic Mechanism of Nicotinamide N-MethyltransferasePMID: 30148963
Loring HS, Thompson PR (2018)
- [3]Safety of high-dose nicotinamide: a reviewPMID: 11126400
Knip M et al. (2000)
- [4]Final report of the safety assessment of niacinamide and niacinPMID: 16596767
Cosmetic Ingredient Review Expert Panel (2005)
- [5]NAD-boosting molecules suppress mast cell degranulation and anaphylactic responses in micePMID: 35547746
Kim DJ et al. (2022)
Common Questions
Written by Ken Chapman, Founder of ZebraThrive. Reviewed and last updated .